Myda Advisors LLC Gemini Therapeutics, Inc. Transaction History

Myda Advisors LLC

  • $407 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$1.31 - $2.01 $56,330 - $86,429
43,000 Added 215.0%
63,000 $103,000
Q2 2022

Aug 12, 2022
BUY
$1.22 - $1.73 $24,400 - $34,600
20,000 New
20,000 $34,000
Q2 2021

Aug 13, 2021
SELL
$6.32 - $14.02 $403,848 - $895,878
-63,900 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$11.32 - $18.0 $723,348 - $1.15 Million
63,900 New
63,900 $866,000

Others Institutions Holding GMTX

# of Institutions
1
Shares Held
2.44M
Call Options Held
0
Put Options Held
0
View Full List

About Gemini Therapeutics, Inc.

GMTX Quotes by TradingView
  • Ticker GMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,244,500
  • Market Cap $1.05B
  • Description
  • Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...
More about GMTX
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email